Ordinary Index Rebalancing in the North American Psychedelics Index | March 2022

In the ordinary rebalance the following composition will be implemented over the period starting at cob 17.03.2022 and ending at cob 18.03.2022. The final index composition will be effective at the open 21.03.2022.

ABBVIE INC
ATAI LIFE SCIENCES B.V
Compass Pathways PLC
CYBIN INC
ENVERIC BIOSCIENCES INC
FIELD TRIP HEALTH LTD
GH RESEARCH PLC
GREENBROOK TMS INC
JOHNSON & JOHNSON
MIND MEDICINE MINDMED INC
MINDSET PHARMA INC
MYDECINE INNOVATIONS GROUP INC
NUMINESS WELLNESS INC
OPTIMI HEALTH CORP
PHARMATHER HOLDINGS LTD
REVIVE THERAPEUTICS LTD
SEELOS THERAPEUTICS INC
RED LIGHT HOLLAND CORP